Report cover image

Drug Discovery Services Market by Process (Candidate Validation, Hit-to-Lead Identification, Lead Optimization), Drug Type (Biologics, Small Molecules), Service type, Therapeutic Area, End-user - Global Forecast 2024-2030

Publisher 360iResearch
Published Jan 15, 2024
Length 182 Pages
SKU # IRE18442952

Description

Drug Discovery Services Market by Process (Candidate Validation, Hit-to-Lead Identification, Lead Optimization), Drug Type (Biologics, Small Molecules), Service type, Therapeutic Area, End-user - Global Forecast 2024-2030


The Drug Discovery Services Market size was estimated at USD 21.77 billion in 2023 and expected to reach USD 24.79 billion in 2024, at a CAGR 14.37% to reach USD 55.75 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Drug Discovery Services Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Drug Discovery Services Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Drug Discovery Services Market, highlighting leading vendors and their innovative profiles. These include Aganitha AI Inc., Agilent Technologies, Inc., Aurigene Discovery Technologies, BellBrook Labs, BioAscent Discovery Ltd., Charles River Laboratories International, Inc., Domainex Ltd., Enzo Life Sciences Inc., Eurofins Scientific SE, Frontage Laboratories, Inc., GenScript Biotech Corporation, Integrated DNA Technologies, Inc., IQVIA Inc, Jubilant Biosys Ltd., Labcorp Drug Development, Merck KGaA, Piramal Pharma Solutions, Proteros biostructures GmbH, Sai Life Sciences Limited, Schrödinger, Inc., Selvita S.A., Shanghai ChemPartner, Shanghai Medicilon, Inc., Symeres, Syngene International Limited, TCG Lifesciences Pvt. Limited, Thermo Fisher Scientific Inc., UCB S.A., Viva Biotech, and Wuxi Apptec.

Market Segmentation & Coverage

This research report categorizes the Drug Discovery Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

Process
Candidate Validation

Hit-to-Lead Identification

Lead Optimization

Target Selection

Target Validation
Drug Type
Biologics

Small Molecules
Service type
Biology Services

Chemistry Services
Therapeutic Area
Cardiovascular Diseases

Digestive System Diseases

Neurology

Oncology
End-user
Academic Institutes

Pharmaceutical & Biotechnology Companies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas

Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam

Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Drug Discovery Services Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Drug Discovery Services Market?
3. What are the technology trends and regulatory frameworks in the Drug Discovery Services Market?
4. What is the market share of the leading vendors in the Drug Discovery Services Market?
5. Which modes and strategic moves are suitable for entering the Drug Discovery Services Market?PDF E-mail From Publisher (2-5)Users License

Table of Contents

182 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drug Discovery Services Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing R&D investments in the pharmaceutical & biopharmaceutical industry
5.1.1.2. Attractive rise in demand for outsourcing analytical testing and clinical trial services
5.1.1.3. Research on rare diseases and orphan drugs
5.1.2. Restraints
5.1.2.1. Expensive drug discovery and development
5.1.3. Opportunities
5.1.3.1. Development in the biologics and focus on drug discovery
5.1.3.2. Potential associated with expiry of patents
5.1.4. Challenges
5.1.4.1. Strict government rules for drug discovery and animal usage
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Drug Discovery Services Market, by Process
6.1. Introduction
6.2. Candidate Validation
6.3. Hit-to-Lead Identification
6.4. Lead Optimization
6.5. Target Selection
6.6. Target Validation
7. Drug Discovery Services Market, by Drug Type
7.1. Introduction
7.2. Biologics
7.3. Small Molecules
8. Drug Discovery Services Market, by Service type
8.1. Introduction
8.2. Biology Services
8.3. Chemistry Services
9. Drug Discovery Services Market, by Therapeutic Area
9.1. Introduction
9.2. Cardiovascular Diseases
9.3. Digestive System Diseases
9.4. Neurology
9.5. Oncology
10. Drug Discovery Services Market, by End-user
10.1. Introduction
10.2. Academic Institutes
10.3. Pharmaceutical & Biotechnology Companies
11. Americas Drug Discovery Services Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Drug Discovery Services Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Drug Discovery Services Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Aganitha AI Inc.
15.1.2. Agilent Technologies, Inc.
15.1.3. Aurigene Discovery Technologies
15.1.4. BellBrook Labs
15.1.5. BioAscent Discovery Ltd.
15.1.6. Charles River Laboratories International, Inc.
15.1.7. Domainex Ltd.
15.1.8. Enzo Life Sciences Inc.
15.1.9. Eurofins Scientific SE
15.1.10. Frontage Laboratories, Inc.
15.1.11. GenScript Biotech Corporation
15.1.12. Integrated DNA Technologies, Inc.
15.1.13. IQVIA Inc
15.1.14. Jubilant Biosys Ltd.
15.1.15. Labcorp Drug Development
15.1.16. Merck KGaA
15.1.17. Piramal Pharma Solutions
15.1.18. Proteros biostructures GmbH
15.1.19. Sai Life Sciences Limited
15.1.20. Schrödinger, Inc.
15.1.21. Selvita S.A.
15.1.22. Shanghai ChemPartner
15.1.23. Shanghai Medicilon, Inc.
15.1.24. Symeres
15.1.25. Syngene International Limited
15.1.26. TCG Lifesciences Pvt. Limited
15.1.27. Thermo Fisher Scientific Inc.
15.1.28. UCB S.A.
15.1.29. Viva Biotech
15.1.30. Wuxi Apptec
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
FIGURE 1. DRUG DISCOVERY SERVICES MARKET RESEARCH PROCESS
FIGURE 2. DRUG DISCOVERY SERVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. DRUG DISCOVERY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. DRUG DISCOVERY SERVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. DRUG DISCOVERY SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. DRUG DISCOVERY SERVICES MARKET DYNAMICS
FIGURE 7. DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2023 VS 2030 (%)
FIGURE 8. DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
FIGURE 10. DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2030 (%)
FIGURE 12. DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
FIGURE 14. DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 16. DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. DRUG DISCOVERY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. DRUG DISCOVERY SERVICES MARKET SHARE, BY KEY PLAYER, 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us